CDC says mammography screenings declined 87% during initial days of the pandemic

Breast cancer screenings dropped 87% during the initial days of the COVID-19 pandemic, according to new data from the U.S. Centers for Disease Control and Prevention released Wednesday.

The declines were particularly pronounced among low-income populations and women of color. Experts with the CDC are urging radiologists and other providers to remain vigilant amid concerns of more advanced cancers cropping up in the future after patients missed their routine checkups in 2020.

“CDC encourages healthcare professionals to help minimize delays in testing by continuing routine cancer screening for women having symptoms or at high risk for breast or cervical cancer,” Amy DeGroff, PhD, a health scientist for the agency and lead author of the study, said in a statement

For the study, scientists looked to data from the CDC’s National Breast and Cervical Cancer Early Detection Program, which provides screening services for disadvantaged populations. They found that mammography screenings plummeted nearly 90% in April 2020 when compared to previous five-year averages for the same month. Cervical cancer screenings, meanwhile, fell 84%.

These breast imaging declines persisted across metro (86%), urban (88%) and rural (89%) areas. And certain minority populations such as Latina women (84%) and American Indian/Alaskan native women (98%) were hit harder, DeGroff and colleagues reported. However, screening volumes had begun to recover across all groups by June 2020.

Causes for the decline likely included screening site closures, stay-at-home orders, and the temporary suspension of mammography and other nonurgent services. The investigation is the latest in a series of studies highlighting COVID-19’s outsized impact on imaging, including one with similar results published May 24 in JAMA Network Open.

You can read the full CDC investigation, shared June 30 in Preventive Medicine, here.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup